IP Verse

Alexion Pharmaceuticals vs. Amgen Technology (Ireland) Unlimited Company - APL_40553/2024

Explore detailed information on the case number APL_40553/2024 involving Alexion Pharmaceuticals and Amgen Technology (Ireland) Unlimited Company, Amgen N.V., Amgen Gmbh, and others which was filed on 11 Jul, 2024.

Case Details

    Case Number:

    APL_40553/2024

    Patent Number:

    EP3167888

    Filing Date:

    11 Jul, 2024

    Proceeding Type:

    Appeal

    Action/Application:

    Appeal Rop220.1

    Decision Date:

    20 Dec, 2024

    Plaintiffs:

    • Alexion Pharmaceuticals, Inc. Represented By Elena Hennecke

    Defendants:

    • Amgen Technology (Ireland) Unlimited Company Represented By Tilman Muller-Stoy
    • Amgen N.V. Represented By Tilman Muller-Stoy
    • Amgen Gmbh Represented By Tilman Muller-Stoy
    • Amgen Ab Represented By Tilman Muller-Stoy
    • Amgen S.A.S. Represented By Tilman Muller-Stoy
    • Amgen S.R.L. Represented By Tilman Muller-Stoy
    • Amgen Biofarmaceutica Lda. Represented By Tilman Muller-Stoy
    • Amgen Zdravila D.O.O. Represented By Tilman Muller-Stoy

    Judges:

    • Ingeborg Simonsson
    • Patricia Rombach
    • Rian Kalden

    Court Division:

    Appeal Instance - Seat - Luxembourg

Case Decision

    Decision Date:

    Dec 20, 2024

    Decision Document:

More cases on EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ACT_59173/2024Oct 31, 2024Amgen Switzerland Ag Vilniaus FilialasAlexion Pharmaceuticals
APL_40470/2024Jul 11, 2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.
ACT_13849/2024Mar 19, 2024Alexion PharmaceuticalsSamsung Bioepis Nl B.V.

More cases on Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
App_8339/2025Mar 6, 2025Alexion Pharmaceuticals -
App_8340/2025Mar 6, 2025Alexion Pharmaceuticals -
ORD_55359/2024Oct 9, 2024Alexion PharmaceuticalsSamsung Bioepis NL

More cases on Amgen Technology (Ireland) Unlimited Company

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Aug 21, 2025
Case NumberFiling DatePlaintiffsDefendants
ORD_55360/2024Oct 9, 2024Alexion PharmaceuticalsAmgen Zdravila DOO, Amgen, Amgen, Amgen, Amgen, Amgen Technology Ireland Unlimited, Amgen AB, Amgen Biofarmaceutica LDA
ORD_42898/2024Jul 22, 2024Alexion PharmaceuticalsAmgen Biofarmaceutica LDA, Amgen, Amgen Technology Ireland Unlimited, Amgen, Amgen, Amgen Zdravila DOO, Amgen AB, Amgen
ORD_35789/2024Jun 14, 2024Alexion PharmaceuticalsAmgen, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen, Amgen AB, Amgen, Amgen, Amgen Zdravila DOO